Academy of Physicians
in Clinical Research

Academy of Physicians
in Clinical Research




News from SCRIP

APCR Members can get a free trial to SCRIP and a discount on a SCRIP subscription by contacting John Lezcano from SCRIP directly at the information below. 

John Lezcano
Corporate Account Manager

Pharma intelligence | informa
T: (212) 652-2678
M: (631) 807-4971
John.lezcano@informa.com
pharmaintelligence.informa.com

Roche Secures Dicerna RNAi Deal For Hepatitis B

Fri, 11/01/2019 - 10:01am

Roche has paid $200m up front to get its hands on Dicerna’s RNAi-based drug for chronic hepatitis B in a...

      Related Stories 

Novartis's Cosentyx Fails To EXCEED Humira in PsA

Fri, 11/01/2019 - 8:19am

The Swiss major's immunology head tells Scrip that while Cosentyx was unable to beat Humira on the 20% improvement scale...

      Related Stories 

Abbott’s Cloherty On Viral Surveillance And Evolving Viruses

Fri, 11/01/2019 - 3:24am

Gavin Cloherty, Abbott’s head of infectious disease research, tells Scrip how the company’s global viral surveillance program helps it stay...

      Related Stories 

Amgen Joins China Oncology Market Race With $2.7bn BeiGene Stake

Thu, 10/31/2019 - 11:59pm

As China embraces novel new drugs, oncology is quickly becoming the biggest opportunity for pharma to drive growth in this...

      Related Stories 

Core Global Portfolio Drives Takeda Despite Pockets Of Weakness

Thu, 10/31/2019 - 6:19pm

Japanese firm raises full-year forecast for core operating profit on continued growth for global brands, despite US recall and hematology...

      Related Stories 

Bristol Projects Opdivo Sales Will Grow Again In 2021

Thu, 10/31/2019 - 3:43pm

With new Opdivo/Yervoy combination data in first-line lung cancer, the company expects the PD-1 inhibitor’s growth to go from flat...

      Related Stories 

Catalyst Will Try To Salvage Rare Disease Drug from Failed Phase III Trial

Thu, 10/31/2019 - 2:28pm

Despite a Phase III study that found no statistically significant outcomes for its endpoints for Firdapse, Catalyst will seek FDA...

      Related Stories 

Finance Watch: BIO Says Proposed Foreign Investment Regulations Will Lower Investment In US Biotech

Wed, 10/30/2019 - 2:31pm

Private Company Edition: BIO comments suggest definitions of personal data expand the scope of foreign investments in biotech companies that...

      Related Stories 

Amgen’s Playing To Its R&D Strengths, Which No Longer Include Neuroscience

Wed, 10/30/2019 - 2:29pm

The company will focus on core therapeutics areas like oncology and cardiovascular disease, but left open the possibility of future...

      Related Stories 

Cyclerion Looking To Partner Praliciguat Despite Phase II Fail In Diabetic Nephropathy

Wed, 10/30/2019 - 2:06pm

The Ironwood spinout thinks its sGC stimulator demonstrated benefit in reducing urine albumin levels in DN patients; notes data improve...

      Related Stories 

GSK Says Shingrix Shortage, Oncology Push Continues

Wed, 10/30/2019 - 12:23pm

GlaxoSmithKline said its increasingly streamlined operations are on a growth trajectory, but that capacity constraints mean demand for its popular...

      Related Stories 

US FDA Puts IT Zolgensma Studies On Partial Clinical Hold

Wed, 10/30/2019 - 11:10am

The roller coaster ride for Novartis with its high-profile gene therapy Zolgensma continues as the FDA places a partial hold...

      Related Stories 

Roundup Lawsuits Overshadow Pharma Growth At Bayer

Wed, 10/30/2019 - 9:46am

Pharmaceutical sales hit €4.35bn helped by a strong showing in China but as the number of glyphosate plaintiffs in the...

      Related Stories 

Pages